Literature DB >> 23881732

In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity.

Thomas Schwartz1, Helga Sanner2, Ola Gjesdal3, Berit Flatø4, Ivar Sjaastad5.   

Abstract

OBJECTIVE: To compare systolic cardiac function in patients with juvenile dermatomyositis (JDM) with matched controls and examine associations between systolic and diastolic cardiac function and disease variables.
METHODS: Fifty-nine patients, examined at follow-up, median 16.8 years (2-38 years) after disease onset, were compared with 59 age-matched and sex-matched controls. Echocardiography was performed and analysed blinded to patient information. We used mitral annulus displacement to assess the relative long-axis shortening of the left ventricle (long-axis strain) and early diastolic tissue velocity (e'), as markers for systolic and diastolic function, respectively. Disease activity and organ damage were assessed at follow-up by clinical examination and retrospectively by chart review.
RESULTS: Long-axis strain was reduced in patients compared with controls (16.6% (2.5) vs 17.7% (2.0), mean (SD), p=0.001), whereas no difference was seen between patients with active and inactive disease. Disease duration correlated with systolic and diastolic function (rsp=-0.50 and rsp=-0.73, both p<0.001) and so did Myositis Damage Index (MDI) 1 year (rsp=-0.36 and rsp=-0.46) and MDI at follow-up (rsp=-0.33 and rsp=-0.60), all p<0.01. High early disease activity score (DAS) in skin (DAS skin 1 year), but not in muscle, predicted systolic (standardised β=-0.28, p=0.011, R(2)=48%) and diastolic dysfunction (β=-0.36, p<0.001, R(2)=72%) at follow-up.
CONCLUSIONS: Long-axis strain was reduced in JDM patients compared with controls, suggesting systolic dysfunction. Impaired systolic and diastolic function was predicted by DAS skin 1 year. This indicates a common pathway to two different cardiac manifestations in JDM, perhaps with similar pathogenesis as skin affection. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Cardiovascular Disease; Dermatomyositis; Disease Activity; Inflammation

Mesh:

Year:  2013        PMID: 23881732     DOI: 10.1136/annrheumdis-2013-203279

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

Review 1.  Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment.

Authors:  Jian-Qiang Wu; Mei-Ping Lu; Ann M Reed
Journal:  World J Pediatr       Date:  2019-09-26       Impact factor: 2.764

2.  Cardiac function in patients with polymyositis or dermatomyositis: a three-dimensional speckle-tracking echocardiography study.

Authors:  Yue Zhong; Wenjuan Bai; Qibing Xie; Jianhong Sun; Hong Tang; Li Rao
Journal:  Int J Cardiovasc Imaging       Date:  2017-11-22       Impact factor: 2.357

Review 3.  Advances in Juvenile Dermatomyositis: Myositis Specific Antibodies Aid in Understanding Disease Heterogeneity.

Authors:  Lauren M Pachman; Amer M Khojah
Journal:  J Pediatr       Date:  2018-04       Impact factor: 4.406

4.  Fatal Myocarditis in an Adolescent Girl with Evolving Connective Tissue Disease.

Authors:  Bipin Jose; Dantis Emmanuel; Preethy Harrison
Journal:  Indian J Pediatr       Date:  2019-05-10       Impact factor: 1.967

Review 5.  Treatment of Juvenile Dermatomyositis: An Update.

Authors:  Charalampia Papadopoulou; Lucy R Wedderburn
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

6.  Echocardiographic study of juvenile dermatomyositis patients: new insights from speckle-tracking-derived strain.

Authors:  Maria de Fátima Rodrigues Diniz; Katia Tomie Kozu; Adriana Maluf Elias; Alessandro Cavalcanti Lianza; Karen Saori Shiraishi Sawamura; Carolina Rocha Brito Menezes; Juliana Caires de Oliveira Achili Ferreira; Clovis Artur Silva; Gabriela Nunes Leal
Journal:  Clin Rheumatol       Date:  2020-09-28       Impact factor: 2.980

Review 7.  Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.

Authors:  Lisa G Rider; Katalin Dankó; Frederick W Miller
Journal:  Curr Opin Rheumatol       Date:  2014-11       Impact factor: 5.006

8.  213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015.

Authors:  Olivier Benveniste; Lisa G Rider
Journal:  Neuromuscul Disord       Date:  2016-05-27       Impact factor: 4.296

9.  Associations between cardiac and pulmonary involvement in patients with juvenile dermatomyositis-a cross-sectional study.

Authors:  Birgit Nomeland Witczak; Thomas Schwartz; Zoltan Barth; Eli Taraldsrud; May Brit Lund; Trond Mogens Aaløkken; Berit Flatø; Ivar Sjaastad; Helga Sanner
Journal:  Rheumatol Int       Date:  2022-01-04       Impact factor: 3.580

10.  Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damage.

Authors:  Helga Sanner; Thomas Schwartz; Berit Flatø; Maria Vistnes; Geir Christensen; Ivar Sjaastad
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.